(Q46549414)

23 December 2017

title

Electronic pill-boxes in the evaluation of oral hypoglycemic agent compliance (English)

1 reference

23 December 2017

author name string

Charpentier G

1

1 reference

23 December 2017

Fleury F

2

1 reference

23 December 2017

Dubroca I

3

1 reference

23 December 2017

Vaur L

4

1 reference

23 December 2017

Clerson P

5

1 reference

23 December 2017

publication date

1 April 2005

1 reference

23 December 2017

published in

Diabetes and Metabolism

1 reference

23 December 2017

volume

31

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

189-195

1 reference

23 December 2017

Adherence in diabetes: can we define it and can we measure it?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

MSJAMA: the problem with compliance in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Time to stop counting the tablets?

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Dynamics of drug regimen compliance--its assessment by microprocessor-based monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimen.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Impact of dosage frequency on patient compliance.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Changes in treatment after the start of oral hypoglycaemic therapy in Type 2 diabetes: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

The association between diabetes metabolic control and drug adherence in an indigent population

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Antihypertensive medication-taking. Investigation of a simple regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Treatment satisfaction and psychological well-being with insulin glargine compared with NPH in patients with Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

Insulin improves well-being for selected elderly type 2 diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: a placebo-controlled, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970185-4

7 January 2021

10.1016/S1262-3636(07)70185-4

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017